Neurological paraneoplastic syndromes

Neuroscientist

Volumn 4, Issue 6, 1998, Pages 443-453

  Dalmau, Josep O ^a   Posner, Jerome B ^a,b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CALCIUM CHANNEL;

AUTOIMMUNITY; DISEASE CLASSIFICATION; ENCEPHALOMYELITIS; HUMAN; IMMUNOPATHOGENESIS; LUNG SMALL CELL CANCER; LYMPHOMA; MYOCLONUS; NEUROPATHOLOGY; NEUROPATHY; OPSOCLONUS; PARANEOPLASTIC SYNDROME; PATHOPHYSIOLOGY; REVIEW;

EID: 0031738827     PISSN: 10738584     EISSN: None     Source Type: Journal    
DOI: 10.1177/107385849800400616     Document Type: Review

References (54)

1. Posner JB. Neurologic complications of cancer. Philadelphia: FA Davis Company; 1995.
2. Elrington GM, Murray NM, Spiro SG, Newsom-Davis J. Neurological paraneoplastic syndromes in patients with small cell lung cancer. A prospective survey of 150 patients. J Neurol Neurosurg Psychiatry 1991;54:764-767.
3. Henson RA, Urich H. Cortical cerebellar degeneration. In: Henson RA, Urich H, editors. Cancer and the nervous system. Oxford, UK: Blackwell Scientific Publications; 1982. p. 314-345.
4. Lang B, Newsom-Davis J. Immunopathology of the Lambert-Eaton myasthenic syndrome. Semin Immunopathol 1995;17:3-15.
5. Lindstrom JD, Shelton A, Fujii Y. Myasthenia gravis. Adv Immunol 1988;42:233-284.
6. Newsom-Davis J, Murray NM. Plasma exchange and immunosuppressive drug treatment in the Lambert-Eaton myasthenic syndrome. Neurology 1984;34:480-485.
7. Drachman DB. Myasthenia gravis. N Eng J Med 1994;330:1797-1810.
8. Sillevis-Smitt PA, Manley GT, Posner JB. Immunization with the paraneoplastic antigen HuD does not cause neurologic disease in mice. Neurology 1995;45:1873-1878.
9. Tanaka K, Tanaka M, Onodera O, Igarashi S, Miyatake T, Tsuji S. Passive transfer and active immunization with the recombinant leucine-zipper (Yo) protein as an attempt to establish an animal model of paraneoplastic cerebellar degeneration. J Neurol Sci 1994;127:153-158.
10. Dalmau J, Furneaux HM, Gralla RJ, Kris MG, Posner JB. Detection of the anti-Hu antibody in the serum of patients with small cell lung cancer: A quantitative western blot analysis. Ann Neurol 1990;27:544-552.
11. Peterson K, Rosenblum MK, Kotanides H, Posner JB. Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients. Neurology 1992;42:1931-1937.
12. Luque FA, Furneaux HM, Ferziger R, et al. Anti-Ri: An antibody associated with paraneoplastic opsoclonus and breast cancer. Ann Neurol 1991;29:241-251.
13. Furneaux HM, Reich L, Posner JB. Autoantibody synthesis in the central nervous system of patients with paraneoplastic syndromes. Neurology 1990;40:1085-1091.
14. Graus F, Segurado OG, Tolosa E. Selective concentration of anti-Purkinje cell antibody in the CSF of two patients with paraneoplastic cerebellar degeneration. Acta Neurol Scand 1988;78:210-213.
15. Anderson NE, Rosenblum MK, Graus F, Wiley RG, Posner JB. Autoantibodies in paraneoplastic syndromes associated with small cell lung cancer. Neurology 1988;38:1391-1398.
16. Graus F, Ribalta T, Campo E, Monforte R, Urbano A, Rozman C. Immunohistochemical analysis of the immune reaction in the nervous system in paraneoplastic encephalomyelitis. Neurology 1990;40:219-22.
17. Verschuuren J, Chuang L, Rosenblum MK, et al. Inflammatory infiltrates and complete absence of Purkinje cells in anti-Yo associated paraneoplastic cerebellar degeneration. Acta Neuropathol 1996;91:519-525.
18. Dalmau J, Furneaux HM, Rosenblum MK, Graus F, Posner JB. Detection of the anti-Hu antibody in specific regions of the nervous system and tumor from patients with paraneoplastic encephalomyelitis/sensory neuronopathy. Neurology 1991;41:1757-1764.
19. Jean WC, Dalmau J, Ho A, Posner JB. Analysis of the IgG subclass distribution and inflammatory infiltrates in patients with anti-Hu associated paraneoplastic encephalomyelitis. Neurology 1994; 44:140-147.
20. Dalmau J, Furneaux HM, Cordon-Cardo C, Posner JB. The expression of the Hu (paraneoplastic encephalomyelitis/sensory neuronopathy) antigen in human normal and tumor tissues. Am J Pathol 1992;141:881-886.
21. Dalmau J, Graus F, Cheung NK, et al. Major histocompatibility proteins, anti-Hu antibodies, and paraneoplastic encephalomyelitis in neuroblastoma and small cell lung cancer. Cancer 1995;75:99-109.
22. Liu S, Mezrich J, Berk J, Federici M, Dalmau J, Posner JB. Expression of Purkinje-cell antigens in ovarian tumor, and presence of anti-Purkinje cell antibodies in the serum of patients without paraneoplastic cerebellar degeneration [abstract]. Neurology 1995; 45(Suppl 4):A228-A229.
23. Nobile-Orazio E, Manfredini E, Carpo M, et al. Frequency and clinical correlates of anti-neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy. Ann Neurol 1994; 36:416-424.
24. Vallat JM, De Mascarel HA, Bordessoule D, et al. Non-Hodgkin's malignant lymphomas and peripheral neuropathies - 13 cases. Brain 1995;118:1233-1245.
25. Gieron MA, Margraf LR, Korthals JK, Gonzalvo AA, Murtagh RF, Hvizdala EV. Progressive necrotizing myelopathy associated with leukemia: clinical, pathologic, and MRI correlation. J Child Neurol 1987;2:44-49.
26. Denny-Brown D. Primary sensory neuropathy with muscular changes associated with carcinoma. J Neurol Neurosurg Psychiatry 1948;11:73-87.
27. Brain WR, Daniel PM, Greenfield JG. Subacute cortical cerebellar degeneration and its relation to carcinoma. J Neurol Neurosurg Psychiatry 1951;14:59-75.
28. Henson RA, Hoffman HL, Urich H. Encephalomyelitis with carcinoma. Brain 1965;88:449-64.
29. Elmqvist D, Lambert EH. Detailed analysis of neuromuscular transmission in a patient with the myasthenic syndrome sometimes associated with bronchogenic carcinoma. Mayo Clin Proc 1968; 43:689-713.
30. Mancall EL, Rosales RK. Necrotizing myelopathy associated with visceral carcinoma. Brain 1964;87:639-659.
31. Dalmau J, Graus F, Rosenblum MK, Posner JB. Anti-Hu associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients. Medicine 1992;71:59-72.
32. Mason WP, Graus F, Lang B, et al. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome. Brain 1997;120:1279-1300.
33. Graus F, Dalmau J, Valldeoriola F, et al. Immunological characterization of a neuronal antibody (anti-Tr) associated with paraneoplastic cerebellar degeneration and Hodgkin's disease. J Neuroimmunol 1997;74:55-61.
34. Graus F, Dalmau J, Rene R, et al. Anti-Hu antibodies in patients with small cell lung cancer: association with complete response to therapy and improved survival. J Clin Oncol 1997;15:2866-2872.
35. Hetzel DJ, Stanhope R, O'Neill BP, Lennon VA. Gynecologic cancer in patients with subacute cerebellar degeneration predicted by anti-Purkinje cell antibodies and limited in metastatic volume. Mayo Clin Proc 1990;65:1558-1563.
36. Dalmau J, Graus F. Paraneoplastic syndromes of the nervous system. In: Black PMcL, Loeffler JS, editors. Cancer of the nervous system. Oxford, UK: Blackwell Scientific Publications; 1997. p. 674-700.
37. Dirr LY, Elster AD, Donofrio PD, Smith M. Evolution of brain MRI abnormalities in limbic encephalitis. Neurology 1990;40: 1304-1306.
38. Glantz MJ, Biran H, Myers ME, Gockerman JP, Friedberg MH. The radiographic diagnosis and treatment of paraneoplastic central nervous system disease. Cancer 1994;73:168-175.
39. Alamowitch S, Graus F, Uchuya M, Reñé R, Bescansa E, Delattre J-Y. Limbic encephalitis and small cell lung cancer: clinical and immunological features. Brain 1997;120:923-928.
40. Ito H, Sayama S, Irie S, et al. Antineuronal antibodies in acute cerebellar ataxia following Epstein-Barr virus infection. Neurology 1994;44:1506-1507.
41. Saiz A, Arpa J, Sagasta A, et al. Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity. Neurology 1997;49:1026-1030.
42. Brashear HR, Greenlee JE, Jaeckle KA, Rose JW. Anticerebellar antibodies in neurologically normal patients with ovarian neoplasm. Neurology 1989;39:1605-1609.
43. O'Neill JH, Murray NMF, Newsom-Davis J. The Lambert-Eaton myasthenic syndrome. A review of 50 cases. Brain 1988;111:577-596.
44. Motomura M, Lang B, Johnston I, Palace J, Vincent A, Newsom-Davis J. Incidence of serum anti-P/Q-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome. J Neurol Sci 1997;147:35-42.
45. Chalk CH, Murray NM, Newsom-Davis J, O'Neill JH, Spiro SG. Response of the Lambert-Eaton myasthenic syndrome to treatment of associated small-cell lung carcinoma. Neurology 1990;40: 1552-1556.
46. Bain PG, Motomura M, Newsom-Davis J, et al. Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndrome. Neurology 1996;47:678-683.
47. Chalk CH, Windebank AJ, Kimmel DW, et al. The distinctive clinical features of paraneoplastic sensory neuronopathy. Can J Neurol Sci 1992;19:346-351.
48. Cohn SL, Salwen H, Herst CV, et al. Single copies of the N-myc oncogene in neuroblastomas from children presenting with the syndrome of opsoclonus-myoclonus. Cancer 1988;62:723-726.
49. Connolly AM, Pestronk A, Mehta S, Pranzatelli MR, Noetzel MJ. Serum autoantibodies in childhood opsoclonus-myoclonus syndrome: an analysis of antigenic targets in neural tissues. J Pediatrics 1997;130:878-884.
50. Russo C, Cohn SL, Petruzzi MJ, Alarcon PA. Long-term neurologic outcome in children with opsoclonus-myoclonus associated with neuroblastoma: a report from the pediatric oncology group. Med Pediatr Oncol 1997;28:284-288.
51. Anderson NE, Budde-Steffen C, Rosenblum MK, et al. Opsoclonus, myoclonus, ataxia, and encephalopathy in adults with cancer: A distinct paraneoplastic syndrome. Medicine 1988;67:100-109.
52. Casado JL, Gil-Peralta A, Graus F, Arenas C, Lopez JM, Alberca R. Anti-Ri antibodies associated with opsoclonus and progressive encephalomyelitis with rigidity. Neurology 1994;44:1521-1522.
53. Dropcho EJ, Kline LB, Riser J. Antineuronal (anti-Ri) autoantibodies in a patient with steroid-responsive opsoclonus myoclonus. Neurology 1993;43:207-211.
54. Shillito P, Molenaar PC, Vincent A, et al. Acquired neuromyotonia: evidence for autoantibodies directed against K+ channels of peripheral nerves. Ann Neurol 1995;38:714-722.